Atlas Trials

Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus

Clinical trial NCT06421701 · UNKNOWN

Trial details

NCT number
NCT06421701
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus
Start date
2024-08-01
Primary completion
2025-08-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.